The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04830137
Recruitment Status : Active, not recruiting
First Posted : April 2, 2021
Last Update Posted : November 7, 2023
Sponsor:
Information provided by (Responsible Party):
Nurix Therapeutics, Inc.